Viral vaccines and vaccine vectors are indexed below.
__________
antibody conjugates - Aug., 5,332,567
antigen/anti-immunoglobulin antibody conjugates - Feb., 5,283,323
avian RNA tumor virus, PrASV - Sep., 5,338,674
avipoxviruses - Mar., 5,286,639
bovine coronavirus - Dec., 5,369,026
canarypox virus - Sep., 5,338,683
canine parvovirus - June, 5,316,764
cationic lipids - Feb., 5,283,185
cytomegalovirus - June, 5,314,800
enterovirus - Apr., 5,298,413; 5,298,416
entomopox virus - Sep., 5,338,679
Epstein-Barr virus - Jan. 95, 5,374,517
equine herpesvirus type 1 - Mar., 5,292,653
feline calici virus - Jan. 95, 5,374,424
feline herpesvirus - July, 5,324,664
feline leukemia virus - May, 5,306,493; Oct., 5,352,449; Jan. 95, 5,374,424
feline panleukopenia virus - Jan. 95, 5,374,424
feline rhinotracheitis virus - Jan. 95, 5,374,424
fowlpox virus - Aug., 5,332,676; Sep., 5,338,683; Dec., 5,368,855; 5,369,025; Jan. 95, 5,374,558
hapten-solid support complexes - Feb., 5,283,066
hepatitis A virus - Apr., 5,294,548
hepatitis B virus - June, 5,314,808; July, 5,324,513; Sep., 5,340,575; Oct., 5,349,059
hepatitis C virus - Apr., 5,298,394; June, 5,312,737; 5,372,928
herpes simplex virus - Mar., 5,288,641; Aug., 5,328,688
herpes simplex virus vectors - Mar., 5,288,641
herpesviruses - Sep., 5,338,683; Jan. 95, 5,374,517
HIV - Mar., 5,286,852; 5,292,636; June, 5,310,876; Aug., 5,328,835; 5,334,394; 5,336,758; Sep., 5,338,829; Oct., 5,346,989
HIV-2 - May, 5,306,614; June, 5,312,902; Dec., 5,364,93
HIV-3 - May, 5,304,466
HTLV-2 - Feb., 5,283,320
human papillomavirus - Sep., 5,342,930
infectious bursal disease virus - Oct., 5,350,575
infectious hematopoietic necrosis virus - Nov., 5,354,555
infectious laryngotracheitis virus - Feb., 5,279,965
influenza A - Mar., 5,290,686
influenza B - Jan. 95, 5,374,717
influenza - Mar., 5,292,506; June, 5,316,910
liposomal adjuvants - June, 5,312,620; Sep., 5,340,588
liposomes - Mar., 5,292,524
Marek's disease virus - Feb., 5,283,191; Dec., 5,369,025
microcapsules - Feb., 5,286,495
muramyldipeptide adjuvants - Jan. 95, 5,376,369
Newcastle disease virus - Mar., 5,286,639
parainfluenza virus type 3 - Feb., 5,284,764
parvovirus - May, 5,302,517
piperidines, phenoxy- deriv. - Dec., 5,364,865
platelet encapsulation - Mar., 5,292,524
poliovirus - Mar., 5,286,640; Apr., 5,298,413; 5,298,416
pseudorabies virus - Oct., 5,352,575; 5,352,596
rabies virus - Oct., 5,348,741
respiratory syncytial virus - Mar., 5,288,630
retroviral particle, type a - Dec., 5,364,757
retroviruses - July, 5,324,645
reverse transcriptase inhibitors - Sep., 5,344,774
rhinovirus - Apr., 5,298,413; 5,298,416; May, 5,304,636
rhinovirus receptors - May, 5,304,636
rotavirus - Apr., 5,298,244; 5,332,658; Jan. 95, 5,374,426
rubella virus - Apr., 5,298,596
Sendai virus - Mar., 5,292,524
Sjogren's syndrome - Sep., 5,344,774
systemic lupus erythematosus - Dec., 5,364,757
T-cell differentiation antigens - Mar., 5,292,636
T-cell receptor proteins - Apr., 5,296,353
TIA-1 monoclonal antibody - Apr., 5,298,407
vaccinia virus - Sep., 5,338,679; 5,338,683; Oct., 5,348,741; Dec., 5,364,773
varicella-zoster virus - May, 5,306,635; 5,310,668; Dec., 5,360,736
vectors - Dec., 5,364,773
virosome vaccines - Mar., 5,292,506
Immune modulators, stimulants and vaccine adjuvants are indexed below.
__________
acemannan - May, 5,308,838
antigen/anti-immunoglobulin antibody conjugates - Feb., 5,283,323
B-cell CR2 receptors - May, 5,310,729
B-cell differentiation factor - July, 5,324,640
benzothiadiazine 1-oxide, 3,4-dihydro-1-phenyl-3-thio-1,2,4- - July, 5,321,024
bile powder - May, 5,302,391
gamma signal peptide - July, 5,324,655
garlic - May, 5,302,391
human growth hormone - June, 5,317,012
imexon - Dec., 5,369,119
immunoadheson - Aug., 5,336,603
interferon - July, 5,324,655; Jan. 95, 5,376,567
interferon, gamma- - Feb., 5,284,937; May, 5,308,626
interferon, leukocyte - Jan. 95, 5,372,808
interferon, unglycosylated - Feb., 5,278,286
interferon-gamma - Dec., 5,362,490
interferon-omega - July, 5,317,089
interleukin-11 - Jan. 95, 5,371,193
interleukin-2 receptors - July, 5,317,087
interleukin-2 - May, 5,308,626; June, 5,312,903; Jan. 95, 5,374,549
interleukin-2/antibody fusion proteins - Oct., 5,349,053
interleukin-4 - Jan. 95, 5,374,549
licorice - May, 5,302,391
liposomal adjuvants - Mar., 5,292,524; June, 5,312,620
lymphocyte activation antigen HB15 - June, 5,316,920
microcapsules - Feb., 5,286,495
muramyldipeptide deriv. - Mar., 5,292,506; Jan. 95, 5,376,369
NK cell activating factor - June, 5,316,933
peptides - Apr., 5,298,490
phagocytosable particles - Mar., 5,292,513
platelet encapsulation - Mar., 5,292,524
poly I:poly(cytidylate/4-thiouridylate) - Apr., 5,298,614
POP-POE block polymers - Jan. 95, 5,376,369
proteoglycan - June, 5,317,085
quillaja - May, 5,302,391
quinolin-4-amines, 1H-imidazo(4,5-c)- - Oct., 5,346,905
soy protein hydrolysate - Aug., 5,330,972
T-cell proteins - June, 5,312,733
tetra-polyols - Jan. 95, 5,376,369
thymosin alpha 1 - May, 5,308,833
TIA-1 monoclonal antibody - Apr., 5,298,407
tissue factor, recombinant - Apr., 5,298,599
tumor necrosis factor antagonists - May, 5,304,634; Nov., 5,359,039
tumor necrosis factor - July, 5,324,655
ureas and urethanes - June, 5,312,831
virosome vaccines - Mar., 5,292,506
Patents are indexed below by the countries where their assignees are located. Note, patents solely assigned to U.S. organizations (240 or 66%) are not listed.
__________
Australia - Apr., 5,298,612; Aug., 5,332,658; 5,334,504; Oct., 5,350,575; Dec., 5,360,817; 5,368,855; Jan. 95, 5,374,517
Austria - Sep., 5,340,575
Canada - Apr., 5,298,244; 5,298,596; May, 5,308,608; June, 5,314,914; Sep., 5,338,679; Nov., 5,359,029; Dec., 5,362,442; 5,369,026; Jan. 95, 5,374,426
Canada and U.S. - Feb., 5,283,185; 5,283,255; Dec., 5,360,734
Czechoslovakia - May, 5,302,585; Nov., 5,352,786
Belgium - May, 5,292,505; 5,302,585
Denmark - June, 5,315,016
France - May, 5,304,559; 5,306,614; 5,310,651; June, 5,312,902; 5,314,808; July, 5,324,513; 5,326,761; Sep., 5,342,930; Nov., 5,358,937; Dec., 5,364,933; Jan. 95, 5,374,519
Germany - Feb., 5,278,152; May, 5,300,643; 5,304,634; 5,304,636; June, 5,310,876; July, 5,317,089; 5,321,024; Aug., 5,334,612; 5,334,711; Nov., 5,358,845; Dec., 5,362,624; 5,364,931; 5,369,119; Jan. 95, 5,371,107
Germany and U.S. - Nov., 5,359,044
Hungary - Mar., 5,292,505
Italy - Feb., 5,278,184; 5,279,944; 5,284,937; Mar., 5,288,704; Apr., 5,298,391; Aug., 5,332,674; Jan. 95, 5,374,626
Japan - Feb., 5,280,111; 5,281,577; 5,283,177; 5,283,239; 5,283,331; Mar., 5,286,639; 5,288,616; 5,290,927; 5,292,506; Apr., 5,298,394; 5,298,614; May, 5,300,636; 5,302,391; 5,302,507; 5,304,731; 5,306,629; June, 5,310,895; 5,316,933; July, 5,318,900; 5,318,972; 5,320,849; 5,324,640; 5,324,645; 5,324,730; 5,326,780; Aug., 5,336,605; Sep., 5,336,770; 5,340,732; 5,340,806; 5,342,840; 5,344,820; Oct., 5,352,665; Nov., 5,352,704; 5,354,653; 5,356,880; Dec., 5,362,490; Jan. 95, 5,371,196; 5,374,549; 5,374,625
Japan and U.S. - Apr., 5,298,419; Dec., 5,369,025; Jan. 95, 5,372,928
Korea - Oct., 5,346,696; 5,348,865
Netherlands - Feb., 5,283,191; Mar., 5,292,738; May, 5,304,466; June, 5,316,764; Oct., 5,348,949; Dec., 5,364,758; Jan. 95, 5,371,079
Sweden - Feb., 5,283,320; 5,284,837; Oct., 5,346,989; Dec., 5,369,129
Switzerland - Apr., 5,294,710
Taiwan - Feb., 5,283,066
U.K. - Apr., 5,298,413; 5,298,416; May, 5,310,671; 5,310,678; Aug., 5,332,676; Nov., 5,356,886; Dec., 5,364,879; Jan. 95, 5,374,558
U.S.A. - all other patents (240) are assigned to U.S. organizations
Venezuela - Oct., 5,346,811
Diagnostics and assays are generally indexed by viral targets, reagents or diseases.
__________
cytomegalovirus - June, 5,314,800; Nov., 5,358,845
Epstein-Barr virus - Jan. 95, 5,374,517; 5,374,520
general - Aug., 5,332,567; Jan. 95, 5,372,929
hepatitis A - Mar., 5,290,677
hepatitis B - Feb., 5,279,944; June, 5,316,936; Dec., 5,362,624
hepatitis C - Apr., 5,298,394; May, 5,302,507; 5,308,750; Oct., 5,350,671; Jan. 95, 5,372,928
herpes simplex virus - Nov., 5,354,653
herpesviruses - Jan. 95, 5,374,517
HIV - Feb., 5,283,177; Mar., 5,286,852; 5,288,640; 5,292,636; Apr., 5,298,391; Aug., 5,334,499; Sep., 5,338,829; 5,344,755; Nov., 5,352,576; 5,356,772; 5,358,845; Jan. 95, 5,374,519; 5,374,531
HIV-2 - May, 5,306,614; 5,310,651; June, 5,312,902; Dec., 5,364,933; Jan. 95, 5,374,518
HIV-3 - May, 5,304,466
HPV - Feb., 5,283,171; Oct., 5,346,811; Dec., 5,364,758
HTLV-I - Nov., 5,356,795; 5,358,845
HTLV-II - Nov., 5,359,029
influenza A - Sep., 5,344,755
influenza B - Jan. 95, 5,374,717
pseudorabies virus - Oct., 5,352,575; 5,352,596
retroviral particle, type a - Dec., 5,364,757
rhinoviruses - Sep., 5,340,713
rotavirus, type C - Feb., 5,283,172
Sjogren's syndrome - Sep., 5,344,774
systemic lupus erythematosus - Dec., 5,364,757
Patents involving recombinant DNA/RNA technologies are indexed below by virus. Entries generally refer to recombinant antigens and viral vectors.
__________
adeno-associated virus - Nov., 5,354,678
avipoxvirus - Mar., 5,286,639
baculoviruses - Mar., 5,288,616; Apr., 5,294,548; May, 5,300,435; July, 5,322,774; Oct., 5,348,886; 5,352,451
bovine coronavirus - Dec., 5,369,026
canarypox virus - Sep., 5,338,683
cauliflower mosaic virus - Oct., 5,352,605
cucumber mosaic virus - May, 5,304,731; Oct., 5,349,128
enterovirus - Apr., 5,298,413
Epstein-Barr virus - Jan. 95, 5,374,517; 5,374,520
equine herpesvirus type 1 - Mar., 5,292,653
feline herpesvirus - July, 5,324,664
fowlpox virus - May, 5,310,671; Aug., 5,332,676; Sep., 5,338,683; Dec., 5,368,855; 5,369,025; Jan. 95, 5,374,558
hepadnaviruses - Aug., 5,334,525; Dec., 5,360,714
hepatitis A virus - Apr., 5,294,548
hepatitis B virus - June, 5,314,808; Sep., 5,340,575; Oct., 5,349,059; Dec., 5,360,714; 5,362,624
hepatitis C virus - May, 5,302,507; June, 5,312,737; Oct., 5,350,671; Jan. 95, 5,371,017; 5,372,928
hepatitis viruses - Aug., 5,334,525
herpes simplex virus - Aug., 5,328,688
herpesviruses - Sep., 5,338,683; Jan. 95, 5,374,517
HIV - Mar., 5,288,640; June, 5,310,876; Aug., 5,328,835; Nov., 5,356,772; Jan. 95, 5,374,519
HIV-2 - May, 5,306,614; Nov., 5,354,683; Dec., 5,364,933
HTLV-I - Nov., 5,359,029
HTLV-II - Nov., 5,359,029
human papillomavirus - Sep., 5,342,930; Jan. 95, 5,376,542
infectious bursal disease virus - Oct., 5,350,575
infectious hematopoietic necrosis virus - Nov., 5,354,555
influenza B - Jan. 95, 5,374,717
Marek's disease virus - Feb., 5,283,191; Dec., 5,369,025
Moloney murine leukemia virus - Feb., 5,278,056; 5,279,965
Newcastle disease virus - Mar., 5,286,639; May, 5,310,678
parainfluenza virus type 3 - Feb., 5,284,764
parvovirus - May, 5,302,517
phage vector - Jan. 95, 5,376,549
poliovirus - Apr., 5,298,413
pseudorabies virus - Oct., 5,352,575; 5,352,596
retroviruses - July, 5,324,645; Dec., 5,364,783
rhinovirus - Apr., 5,298,413
rotavirus - Jan. 95, 5,374,426
TIA-1 monoclonal antibody - Sep., 5,340,935
vaccinia virus - Sep., 5,338,68
varicella-zoster virus - May, 5,306,635; 5,310,668
Patents involving nucleosides, nucleotides and related technologies are listed below.
__________
Feb., 5,278,051; 5,278,302; 5,281,701; Mar., 5,286,717; 5,288,611; 5,290,677; Apr., 5,292,875; 5,298,614; May, 5,306,614; 5,306,629; 5,306,837; 5,310,651; June, 5,310,895; 5,317,085; July, 5,318,972; 5,319,080; 5,324,643; Aug., 5,332,814; 5,334,499; 5,334,711; Sep., 5,336,770; 5,338,671; 5,340,713; 5,340,816; 5,342,840; Oct., 5,346,811; Nov., 5,356,774; 5,359,044; 5,359,051; Dec., 5,360,795; 5,364,758; Jan. 95, 5,372,929; 5,374,625; 5,374,626; 5,376,642
Patents involving antiviral treatments or processing of blood or blood products are listed below.
__________
Feb., 5,281,392; 5,281,579; 5,281,616; 5,283,255; May, 5,300,433; 5,304,113; June, 5,314,878; July, 5,326,788; Sep., 5,340,713; 5,342,752; Dec., 5,360,734; 5,362,442; 5,369,101; Jan. 95, 5,371,196; 5,376,633
Patents involving disinfection, sterilization and related technologies are listed below.
__________
Feb., 5,281,392; 5,281,579; 5,281,616; 5,282,380; 5,283,034; 5,283,255; Mar., 5,286,719; Apr., 5,298,222; May, 5,300,433; 5,304,113; June, 5,314,878; 5,314,917; July, 5,322,856; 5,326,788; Aug., 5,333,626; Sep., 5,338,748; 5,342,752; 5,344,838; Dec., 5,362,442; 5,369,101; Jan. 95, 5,371,196; 5,376,633
Patents involving veterinary applications are listed below.
__________
Feb., 5,279,965; Mar., 5,286,639; 5,292,653; May, 5,302,391; June, 5,316,764; July, 5,324,664; Sep., 5,338,674; 5,338,679; Oct., 5,348,741; 5,350,575; Nov., 5,354,555; 5,359,039; Dec., 5,368,855; 5,369,025; 5,369,026; Jan. 95, 5,374,558